These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22626060)

  • 1. Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.
    Posse de Chaves E
    Can J Physiol Pharmacol; 2012 Jun; 90(6):753-64. PubMed ID: 22626060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?
    Michikawa M
    J Neurosci Res; 2003 Apr; 72(2):141-6. PubMed ID: 12671988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
    Ledesma MD; Dotti CG
    FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol trafficking and amyloid beta peptides.
    Wood WG; Igbavboa U
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin deficiency in Alzheimer's disease brains: causal or casual?
    Dotti CG; Galvan C; Ledesma MD
    Neurodegener Dis; 2004; 1(4-5):205-12. PubMed ID: 16908991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and Alzheimer's disease--is there a relation?
    Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
    Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
    Harris JR; Milton NG
    Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain cholesterol, statins and Alzheimer's Disease.
    Kirsch C; Eckert GP; Koudinov AR; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S113-9. PubMed ID: 14574624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol modulates amyloid beta-peptide's membrane interactions.
    Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for Alzheimer's disease].
    Yanagisawa K
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.